Undervalued Stocks in India List of Undervalued Stocks
The revenue reflects an operational growth of 92%, thanks to Comirnaty, its COVID-19 vaccine that generated over $37 billion. For Q earning report, the company reported a revenue of $27.7 billion, which reflects 53% operational growth and a 47% increase